Arkansas House Bill HB1442

Arkansas 2025 Regular Session

• Introduced: 2/10/25
• Refer: 2/10/25
• Report Pass: 2/27/25
• Engrossed: 3/3/25
• Refer: 3/3/25
• Failed: 5/5/25

Caption

To Set Restrictions On Pharmacy Contracting And Conflicts Of Interest; And To Establish Pharmaceutical Patient Freedom Of Choice.

Impact

If enacted, HB1442 would amend existing pharmacy regulations significantly, stating that all pharmacy permit holders must respect a patient’s freedom to choose their pharmacy. The legislative intent is to enhance patient care outcome quality while ensuring that patients are fully informed of their options when selecting prescriptions or services. It stipulates that any deviations from allowing a patient’s choice could lead to investigations by the Arkansas State Board of Pharmacy, promoting accountability among healthcare providers.

Summary

House Bill 1442 aims to set restrictions on pharmacy contracting and establish pharmaceutical patient freedom of choice in Arkansas. The bill seeks to prevent anti-competitive practices in the pharmacy sector, particularly prohibiting financial incentives that limit a patient’s choice of pharmacy services. One of the key components includes preventing parent entities, such as hospitals and qualified health centers, from incentivizing patients to obtain care from specific pharmacies under varying terms, ensuring equal access to pharmacy services across the board.

Contention

Notably, the bill raises questions concerning potential conflicts of interest, especially regarding the roles of parent entities in pharmacy contracting. Critics might argue that these regulations could complicate relationships between healthcare providers and pharmacies by imposing additional operational requirements. Supporters, however, would argue that the bill ultimately protects patients' rights and prevents monopolistic practices within the pharmacy care industry, safeguarding the integrity of patient-provider relationships.